Central - Tenders Closing By Day
States - Tenders Closing By Day

Closing Today
Closing within 7 days
Closing within 14 days
By Closing Date
Tender Calendar

Central - Tenders Closing for a specific Date

Report For Day : 15-Nov-2025

Total Tenders : 825
Sl.No e-Published Date Bid Submission Closing Date Tender Opening Date Title/Ref.No./Tender Id State Name Corrigendum
341. 24-Oct-2025 03:30 PM 15-Nov-2025 01:30 PM 15-Nov-2025 01:30 PM RIFAXIMIN 200 MG ORAL TABLET/99255180A/106863427 Ministry of Railways --
342. 24-Oct-2025 03:29 PM 15-Nov-2025 01:30 PM 15-Nov-2025 01:30 PM CARBAMAZEPINE 200 MG CR ORAL TABLET/99255169A/106863429 Ministry of Railways --
343. 24-Oct-2025 03:23 PM 15-Nov-2025 01:30 PM 15-Nov-2025 01:30 PM CYCLOSPORIN 50 MG ORAL CAPSULE/99255145A/106863441 Ministry of Railways --
344. 24-Oct-2025 03:21 PM 15-Nov-2025 01:30 PM 15-Nov-2025 01:30 PM HYDROCHLOROTHIAZIDE 12.5 MG AND LOSARTAN POTASSIUM 50 MG ORAL TABLET/99255151A/106863478 Ministry of Railways --
345. 24-Oct-2025 03:02 PM 15-Nov-2025 01:30 PM 15-Nov-2025 01:30 PM ACEBROPHYLLINE 100 MG ORAL CAP/TAB/99255264/106860273 Ministry of Railways --
346. 24-Oct-2025 03:37 PM 15-Nov-2025 01:30 PM 15-Nov-2025 01:30 PM SALMETEROL 50 MCG, FLUTICASONE PROPIONATE 250 MCG ROTOCAPS/99255168A/106863381 Ministry of Railways --
347. 24-Oct-2025 03:35 PM 15-Nov-2025 01:30 PM 15-Nov-2025 01:30 PM OLOPATADINE 0.1 Percent EYE DROPS 5 ML, PRESERVATIVE -BENZALKONIUM CHLORIDE/ CETRIMIDE / SELF PRESERVATIVE./99255074B/106863395 Ministry of Railways --
348. 24-Oct-2025 03:34 PM 15-Nov-2025 01:30 PM 15-Nov-2025 01:30 PM BUDESONIDE 0.5 MG (500MCG) AND FORMOTEROL FUMARATE 20 MCG RESPULES/99255201A/106863402 Ministry of Railways --
349. 24-Oct-2025 03:03 PM 15-Nov-2025 01:30 PM 15-Nov-2025 01:30 PM LEVOSALBUTAMOL 1.25 MG AND IPRATROPIUM BROMIDE 500 MCG RESPULE 3 ML/99255257/106860271 Ministry of Railways --
350. 24-Oct-2025 03:05 PM 15-Nov-2025 01:30 PM 15-Nov-2025 01:30 PM METHYLCOBALAMIN 1500 MCG ORAL TAB/CAP/99255254/106860269 Ministry of Railways --

Note : For more details and clarifications, please refer to the respective Portal.